Product Information
GSK-3368715 is an experimental drug that is being used to treat cancer. It has shown strong activity against both solid tumours and leukaemia in animal models. GSK-3368715 inhibits the growth of cancer cells by altering the antigen concentration on the surface of the cell, which triggers a response from the immune system. It also inhibits protein methylation and leads to a decrease in arginine methylation, which may be important for treating Alzheimer's disease and other neurological disorders. The molecule has been shown to inhibit cell growth in experimental studies.
Chemical properties
Technical inquiry about: 3D-EQC01322 GSK-3368715
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
